365 related articles for article (PubMed ID: 17572904)
1. Fetal hematocrit decrease after repeated intravascular transfusions in alloimmunized pregnancies.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2007 Dec; 276(6):595-9. PubMed ID: 17572904
[TBL] [Abstract][Full Text] [Related]
2. Fetal hydrops and other variables associated with the fetal hematocrit decrease after the first intrauterine transfusion for red cell alloimmunization.
Lobato G; Soncini CS
Fetal Diagn Ther; 2008; 24(4):349-52. PubMed ID: 18849608
[TBL] [Abstract][Full Text] [Related]
3. Relationship between obstetric history and Rh(D) alloimmunization severity.
Lobato G; Soncini CS
Arch Gynecol Obstet; 2008 Mar; 277(3):245-8. PubMed ID: 17763861
[TBL] [Abstract][Full Text] [Related]
4. Experience with intrauterine transfusions for severe Rh alloimmunization in a developing country.
Gupte SC; Lulla CP; Kulkarni SS; Korgaonkar SA; Walvekar VR; Merchant RH
J Matern Fetal Med; 1998; 7(6):287-91. PubMed ID: 9848694
[TBL] [Abstract][Full Text] [Related]
5. Treatment of fetal anemia due to red-cell alloimmunization with intrauterine transfusions in the Netherlands, 1988-1999.
van Kamp IL; Klumper FJ; Meerman RH; Oepkes D; Scherjon SA; Kanhai HH
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):731-7. PubMed ID: 15255845
[TBL] [Abstract][Full Text] [Related]
6. The effects of serial intravascular transfusions in ascitic/hydropic RhD-alloimmunized fetuses.
Craparo FJ; Bonati F; Gementi P; Nicolini U
Ultrasound Obstet Gynecol; 2005 Feb; 25(2):144-8. PubMed ID: 15660441
[TBL] [Abstract][Full Text] [Related]
7. The severity of immune fetal hydrops is predictive of fetal outcome after intrauterine treatment.
van Kamp IL; Klumper FJ; Bakkum RS; Oepkes D; Meerman RH; Scherjon SA; Kanhai HH
Am J Obstet Gynecol; 2001 Sep; 185(3):668-73. PubMed ID: 11568796
[TBL] [Abstract][Full Text] [Related]
8. Increased perinatal loss after intrauterine transfusion for alloimmune anaemia before 20 weeks of gestation.
Lindenburg IT; van Kamp IL; van Zwet EW; Middeldorp JM; Klumper FJ; Oepkes D
BJOG; 2013 Jun; 120(7):847-52. PubMed ID: 23551577
[TBL] [Abstract][Full Text] [Related]
9. Fetal middle cerebral artery Doppler to time intrauterine transfusion in red-cell alloimmunization: a randomized trial.
Dodd JM; Andersen C; Dickinson JE; Louise J; Deussen A; Grivell RM; Voto L; Kilby MD; Windrim R; Ryan G;
Ultrasound Obstet Gynecol; 2018 Mar; 51(3):306-312. PubMed ID: 28700818
[TBL] [Abstract][Full Text] [Related]
10. Prediction of severe fetal anemia in red blood cell alloimmunization after previous intrauterine transfusions.
Scheier M; Hernandez-Andrade E; Fonseca EB; Nicolaides KH
Am J Obstet Gynecol; 2006 Dec; 195(6):1550-6. PubMed ID: 16796991
[TBL] [Abstract][Full Text] [Related]
11. [Intrauterine transfusión in alloimmunization Rh in México 1987-2008].
Ramírez-Robles LJ; Gómez-Partida G; Guevara-Rubio G; Velázquez-Gómez L
Ginecol Obstet Mex; 2010 Sep; 78(9):469-77. PubMed ID: 21961364
[TBL] [Abstract][Full Text] [Related]
12. Rh disease: intrauterine intravascular fetal blood transfusion by cordocentesis.
Onderoğlu L; Oncüloğlu C
Turk J Pediatr; 1999; 41(1):61-5. PubMed ID: 10770677
[TBL] [Abstract][Full Text] [Related]
13. High-dose gammaglobulin (IVIG) followed by intrauterine transfusions (IUTs): a new alternative for the treatment of severe fetal hemolytic disease.
Voto LS; Mathet ER; Zapaterio JL; Orti J; Lede RL; Margulies M
J Perinat Med; 1997; 25(1):85-8. PubMed ID: 9085208
[TBL] [Abstract][Full Text] [Related]
14. Determination of optimal timing of serial in-utero transfusions in red-cell alloimmunization.
Friszer S; Maisonneuve E; Macé G; Castaigne V; Cortey A; Mailloux A; Pernot F; Carbonne B
Ultrasound Obstet Gynecol; 2015 Nov; 46(5):600-5. PubMed ID: 25523966
[TBL] [Abstract][Full Text] [Related]
15. Advantages of larger volume, less frequent intrauterine red blood cell transfusions for maternal red cell alloimmunization.
Inglis SR; Lysikiewicz A; Sonnenblick AL; Streltzoff JL; Bussel JB; Chervenak FA
Am J Perinatol; 1996 Jan; 13(1):27-33. PubMed ID: 8645382
[TBL] [Abstract][Full Text] [Related]
16. Predicting Intrauterine Transfusion Interval and Perinatal Outcomes in Alloimmunized Pregnancies: Time-to-Event Survival Analysis.
Snelgrove JW; D'Souza R; Seaward PGR; Windrim R; Kelly EN; Ryan G
Fetal Diagn Ther; 2019; 46(6):425-432. PubMed ID: 31195389
[TBL] [Abstract][Full Text] [Related]
17. High additional maternal red cell alloimmunization after Rhesus- and K-matched intrauterine intravascular transfusions for hemolytic disease of the fetus.
Schonewille H; Klumper FJ; van de Watering LM; Kanhai HH; Brand A
Am J Obstet Gynecol; 2007 Feb; 196(2):143.e1-6. PubMed ID: 17306657
[TBL] [Abstract][Full Text] [Related]
18. [Blood group immunization: results of treatment of fetal anemia with intra-uterine intravascular blood transfusion in the Netherlands, 1987-1995].
van Kamp IL; Klumper FJ; Meerman RH; Brand A; Bennebroek Gravenhorst J; Kanhai HH
Ned Tijdschr Geneeskd; 1999 Dec; 143(50):2527-31. PubMed ID: 10627756
[TBL] [Abstract][Full Text] [Related]
19. Intrauterine transfusions influence fetal leukocyte counts and subsets.
Viëtor HE; Klumper F; Meerman RJ; Brand A; Kanhai HH
Prenat Diagn; 1998 Apr; 18(4):325-31. PubMed ID: 9602477
[TBL] [Abstract][Full Text] [Related]
20. [Analysis and perinatal outcome after intravascular transfusion].
Monico-Ramos R; Ochoa-Flores M; Hernández-Herrera RJ; Flores-Pompa E
Ginecol Obstet Mex; 2011 Jun; 79(6):351-7. PubMed ID: 21966826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
